Upadacitinib in Patients with Moderate-to-Severe Rheumatoid Arthritis: 2-Year Data from Germany, Austria, and Switzerland in the Observational UPHOLD Study
- DOI
- 10.1007/s40744-026-00888-5
- Published
- 2026-11-03
- Container
- Rheumatology and Therapy
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s40744-026-00888-5,
title = {Upadacitinib in Patients with Moderate-to-Severe Rheumatoid Arthritis: 2-Year Data from Germany, Austria, and Switzerland in the Observational UPHOLD Study},
author = {Eugen Feist and Sara Bär and Maren Sieburg and Jacqueline Detert and Johannes Resch-Passini and Heino Prillwitz and Katharina Wiesemann and Sixten Gnüchtel and Pascal S. Roulin and Alexandra Rueben and Andrea Rubbert-Roth},
year = {2026},
journal = {Rheumatology and Therapy},
doi = {10.1007/s40744-026-00888-5},
url = {https://doi.org/10.1007/s40744-026-00888-5}
}RIS
TY - JOUR TI - Upadacitinib in Patients with Moderate-to-Severe Rheumatoid Arthritis: 2-Year Data from Germany, Austria, and Switzerland in the Observational UPHOLD Study AU - Eugen Feist AU - Sara Bär AU - Maren Sieburg AU - Jacqueline Detert AU - Johannes Resch-Passini AU - Heino Prillwitz AU - Katharina Wiesemann AU - Sixten Gnüchtel AU - Pascal S. Roulin AU - Alexandra Rueben AU - Andrea Rubbert-Roth PY - 2026 JO - Rheumatology and Therapy DO - 10.1007/s40744-026-00888-5 UR - https://doi.org/10.1007/s40744-026-00888-5 ER -
APA
Feist, E., Bär, S., Sieburg, M., Detert, J., Resch-Passini, J., Prillwitz, H., Wiesemann, K., Gnüchtel, S., Roulin, P. S., Rueben, A., & Rubbert-Roth, A. (2026). Upadacitinib in Patients with Moderate-to-Severe Rheumatoid Arthritis: 2-Year Data from Germany, Austria, and Switzerland in the Observational UPHOLD Study. Rheumatology and Therapy. https://doi.org/10.1007/s40744-026-00888-5
Source records
- crossref · retrieved 2026-11-10T11:04:17.422Z